Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -2.44% | $ 70.08M | $ 1.71M |
3/31/2025 | -2.71% | $ 68.76M | $ 1.86M |
12/31/2024 | -91.24% | $ 65.29M | $ 59.57M |
9/30/2024 | -21.67% | $ 274.73M | $ 59.54M |
6/30/2024 | -29.34% | $ 198.05M | $ 58.11M |
3/31/2024 | -25.91% | $ 247.33M | $ 64.08M |
12/31/2023 | -2.21% | $ 288.34M | $ 6.37M |
9/30/2023 | -8.63% | $ 73.58M | $ 6.35M |
6/30/2023 | -6.01% | $ 101.98M | $ 6.13M |
3/31/2023 | -0.01% | $ 116.27M | $ 7K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for PYXIS ONCOLOGY INC is calculated as follows: (-1 * CF - Equity [ $ 35K ]) / Market Cap [ $ 0 ]
(=) Buyback Yield [ 0% ]
Minimum
Sep 30, 2022
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |